OncoSpherix’s CEO Keynote Speaker at Meridian Drug Discovery Virtual Conference

OncoSpherix’s CEO, Margaret K Offermann, MD, PhD, is a keynote speaker at the 3^rd Meridian Drug Discovery Virtual Conference on November 19, 2021. She will be presenting an update on the science of OncoSpherix, with special focus on the chemistry of their clinical lead compound. The title of her presentation is “Solving the Insoluble: Critical Decisions in Advancing First-In-Class Small Molecules for Advanced Cancer.” The presentation is from 3:30-4 PM Eastern Time on Friday, November 19, 2021 and is available to registrants. Registration is at https://meridiandrugdiscovery.com.